Testing the PD-1 Inhibitor Pembrolizumab as Maintenance Therapy After Initial Chemotherapy in Metastatic Bladder Cancer
Study Number: 

I 279815

Phase: 
2
Trial categories: 
Urothelial, Transitional Cell
Bladder
Immunotherapy
Antibody therapy
Checkpoint blockade
Principal Investigator: